Sanjeevani Bio-Tech Exim Profile
Key Indicators
- Authorised Capital ₹ 5.60 M
as on 31-07-2024
- Paid Up Capital ₹ 5.60 M
as on 31-07-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.61 Cr
as on 31-07-2024
- Satisfied Charges ₹ 2.20 Cr
as on 31-07-2024
- Revenue -7.93%
(FY 2023)
- Profit -14.66%
(FY 2023)
- Ebitda 81.59%
(FY 2023)
- Net Worth 14.08%
(FY 2023)
- Total Assets 18.63%
(FY 2023)
About Sanjeevani Bio-Tech Exim
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.60 M and a paid-up capital of Rs 5.60 M.
The company currently has active open charges totaling ₹4.61 Cr. The company has closed loans amounting to ₹2.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Bhargav, Abhinav Bhargava, and Ranjana Bhargav serve as directors at the Company.
- CIN/LLPIN
U51397GJ2010PTC061053
- Company No.
061053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sanjeevani Bio-Tech Exim Private Limited offer?
Sanjeevani Bio-Tech Exim Private Limited offers a wide range of products and services, including Bathroom Accessories, Common Disease Medicines, Eye Drops, Pharmaceutical Capsules, Softgel Capsules, Hydroxypropyl Methylcellulose Ophthalmic Solution, Cough Syrup, Pharmaceutical Medicine, Lycopene Syrup, Nutraceuticals.
Who are the key members and board of directors at Sanjeevani Bio-Tech Exim?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Bhargava  | Director | 14-Oct-2011 | Current |
| Rajiv Bhargav | Director | 21-Dec-2011 | Current |
Ranjana Bhargav  | Director | 14-Oct-2011 | Current |
Financial Performance and Corporate Structure Insights of Sanjeevani Bio-Tech Exim.
Sanjeevani Bio-Tech Exim Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.93% decrease. The company also saw a substantial fall in profitability, with a 14.66% decrease in profit. The company's net worth Soared by an impressive increase of 14.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjeevani Bio-Tech Exim?
In 2023, Sanjeevani Bio-Tech Exim had a promoter holding of 90.18% and a public holding of 9.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanjeevani Tech Solutions Private LimitedActive 11 years 2 monthsAbhinav Bhargava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Apr 2024 | ₹3.00 Cr | Open |
Others Creation Date: 24 Feb 2020 | ₹2.38 M | Open |
Others Creation Date: 24 Feb 2020 | ₹4.45 M | Open |
How Many Employees Work at Sanjeevani Bio-Tech Exim?
Unlock and access historical data on people associated with Sanjeevani Bio-Tech Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjeevani Bio-Tech Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjeevani Bio-Tech Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
